Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Blair William & Co. IL

Blair William & Co. IL raised its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 21.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,447 shares of the biotechnology company's stock after acquiring an additional 16,351 shares during the quarter. Blair William & Co. IL owned approximately 0.12% of Axon Enterprise worth $54,349,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. DRW Securities LLC acquired a new position in Axon Enterprise during the 3rd quarter worth $291,000. The Manufacturers Life Insurance Company grew its position in shares of Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company's stock worth $17,440,000 after buying an additional 276 shares in the last quarter. Dai ichi Life Insurance Company Ltd increased its stake in shares of Axon Enterprise by 63.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company's stock worth $1,457,000 after buying an additional 1,418 shares during the period. D.A. Davidson & CO. increased its stake in shares of Axon Enterprise by 0.3% during the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company's stock worth $5,044,000 after buying an additional 44 shares during the period. Finally, Quantbot Technologies LP purchased a new position in Axon Enterprise in the third quarter worth approximately $84,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Buying and Selling

In other news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $12.74 during midday trading on Tuesday, hitting $538.69. The company had a trading volume of 153,902 shares, compared to its average volume of 807,698. The stock has a market cap of $41.28 billion, a price-to-earnings ratio of 139.20, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company's 50 day simple moving average is $588.26 and its 200 day simple moving average is $551.61. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Needham & Company LLC restated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Barclays restated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.